This application proposes to build on studies conducted during the past 5 years which have focused on two pulmonary cytotoxicants, naphthalene (NA) and 1-nitronaphthalene (NN). This work has: 1) demonstrated lung injury for NA at vapor concentrations well below the current occupational standard, 2) shown that the nasal epithelium is a susceptible target for both compounds, 3) identified many of the proteins adducted by reactive metabolites from NA and NN, and 4) demonstrated substantial quantitative differences in rodent vs nonhuman primate lung metabolism of these substrates. Overall, this work has contributed important data for current assessments of the potential human health hazards of these compounds. New methods have been developed which: 1) allow preservation of the lung for transcriptome analysis in well defined subcompartments, 2) allow selective sampling of proteins from airway epithelium facilitating analysis of changes in the airway proteome in response to toxicants and 3) improve analysis of alterations in protein expression by incorporation of a fluorescent internal standard. The foci of the studies proposed are to: 1) delineate differences in cytotoxic injury associated administration of respirable particle/chemical mixtures, 2) understand the importance of protein/nonprotein thiol oxidation in injury, 3) determine whether proteins which are adducted in the lung by reactive NA and NN metabolites are also adducted in susceptible nasal epithelium, 4) determine whether protein profiles and alterations in the metabolome present in nasal and bronchiolar lavage samples reflect injury to nasal and airway epithelium, 5) determine whether the nasal epithelium (and associated lavage sampling) can act as a legitimate surrogate for more distal parts of the lung and 6) delineate the importance of adducts with antioxidant enzymes and proteins involved in protein folding in cytotoxicity. These studies will provide important baseline data for work on the toxicology of 'real world' combustion mixtures. These particulars samples, many of which contain heavy metals, will be evaluated using nasal epithelium in vitro and in respiratory and renal tissue using proteomics approaches in vivo. The project depends upon close collaboration with the Thermal remediation project and will rely on the Analytical core for metabolomic, accelerator and protein mass spectrometry, and on the 'Omics and biostatistics core for proteome and transcriptome analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
2P42ES004699-19
Application #
6900540
Study Section
Special Emphasis Panel (ZES1-SET-A (S4))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
19
Fiscal Year
2005
Total Cost
$158,781
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications